Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial by de Bono, Johann S, Prof, Mehra, Niven, PhD, Scagliotti, Giorgio V, Prof, Castro, Elena, PhD, Dorff, Tanya, MD, Stirling, Adam, MD, Stenzl, Arnulf, Prof, Fleming, Mark T, MD, Higano, Celestia S, MD, Saad, Fred, MD, Buttigliero, Consuelo, PhD, van Oort, Inge M, PhD, Laird, A Douglas, PhD, Mata, Marielena, PhD, Chen, Hsiang-Chun, PhD, Healy, Cynthia G, BS, Czibere, Akos, MD, Fizazi, Karim, Prof

Get full text